Workflow
Mellia®
icon
Search documents
金斯瑞生物科技公布2025年业绩:稳健增长蓄势待发,业务增长迎来再加速
21世纪经济报道· 2026-03-16 02:19
Core Viewpoint - Kingsray Biotech demonstrated robust growth in its business operations for the year ending December 31, 2025, with a revenue of approximately $959.5 million, reflecting a year-on-year increase of 61.4%. The company showcased strong operational resilience and growth potential in a complex market environment [1]. Business Segment Highlights - **Kingsray Life Sciences**: Achieved revenue of approximately $522.1 million, a year-on-year growth of 14.8%. The adjusted gross profit was $267.3 million, up 12.5%. This growth was driven by the synergistic effects of the "gene to protein" integrated platform and a diversified revenue structure from global operations [3]. - **Pioneer Bio**: The CRDMO platform subsidiary reported revenue of approximately $388.7 million, a staggering year-on-year increase of 309.1%. Adjusted gross profit reached $258.4 million, up 1,697.5%. The company capitalized on market opportunities, achieving organic growth exceeding 21% [4]. - **Biosynergy**: Generated revenue of approximately $58.0 million, reflecting a year-on-year growth of 7.9%. Adjusted gross profit was $23.0 million. The company enhanced its AI-driven research platform, achieving record patent applications and significant breakthroughs in research efficiency [5]. Financial Performance Overview - **Revenue**: For 2025, Kingsray recorded revenue of approximately $959.5 million, an increase of $365.0 million from $594.5 million in 2024. This growth was attributed to increased licensing revenue, ongoing commercial promotion investments, and a rise in demand for AI-driven drug development [7]. - **Gross Profit**: The gross profit for 2025 was approximately $553.2 million, up 103.3% from $272.1 million in 2024. The increase was primarily due to higher revenues, especially from the biopharmaceutical development services segment [8]. - **Adjusted Net Profit**: The adjusted net profit for the period was approximately $230.3 million, reflecting a year-on-year growth of 285.0% [12]. Operational and Sustainability Initiatives - Kingsray is advancing automation, digitalization, and the construction of a global production network to create a more efficient and resilient global operational platform. The company successfully completed a brand refresh in 2025, enhancing its customer-centric approach and global brand influence [7]. - In terms of sustainability, Kingsray is actively pursuing ESG practices and has received multiple international recognitions, including an MSCI AA rating and inclusion in the FTSE Social Responsibility Index series [7].